Clinical Trial Update: Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anti-EGFR therapy with IMRT concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma resistant to induction chemother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• IMRT
• anti-EGFR therapy

Snippet

Sponsor: Fudan University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED